The benefits of CGM for patients with T1D – review of the scientific evidence on clinical outcomes and opportunities for NHS funding
Continuous glucose monitoring (CGM) provides people with type 1 diabetes with information on glucose concentration, along with direction and rate of change. Compared with routine self-monitoring of blood glucose, CGM can improve overall glucose measured by HbA1c, reduce exposure to hypoglycaemia, and does so independently of insulin delivery modality. NICE guidance supports the use of CGM for people with recurrent, or severe, hypoglycaemia and for those with impaired awareness of hypoglycaemia. Implementation of NICE Guidance has been achieved in NW London with good outcomes.
- CGM shows magnitude, rate, and direction of glucose changes
- CGM use is associated with a reduction in HbA1c compared with capillary blood glucose monitoring
- CGM is associated with a reduction in exposure to hypoglycaemia
- NICE guidance for children and adults with type 1 diabetes supports the use of CGM in people at highest risk of hypoglycaemia
Wednesday 14th November 2018
12:15 - 12:45